December 2022

Technologies for Antibody Discovery and Generation

2023-01-27T12:50:07-05:00December 23rd, 2022|Articles|

Written by: Vanessa Yoon Calvelo, PhD Published: December 22, 2022 Contents The Great Debate in Antibody Discovery and Generation Traditional Antibody Discovery and Generation Technologies Emerging Antibody Discovery and Generation Technologies Antibody Discovery and Generation Technologies – Advantages and Disadvantages World’s First: Decoding Serum pAbs with Rapid Novor’s REpAb® Technology [...]

October 2022

Characterizing Biomolecular Interactions with Surface Plasmon Resonance

2023-01-27T12:51:41-05:00October 21st, 2022|Articles|

Written by: Vanessa Yoon Calvelo, PhD Updated: January 18, 2023 (Published: September 15, 2022) Contents Analyzing Biomolecular Interactions is Fundamental to Understanding Biological Systems Analytical Techniques for Biomolecular Interactions SPR Applications for Biomolecular Interactions SPR – A golden standard for biomolecular interaction analysis Analyzing Biomolecular Interactions is [...]

September 2022

Antibody Drug Conjugates as Anti-Cancer Therapeutics

2023-01-27T13:34:44-05:00September 19th, 2022|Articles|

Written by: Genya Gorshtein, MSc Published: September 14, 2022 Contents Introduction ADCs as Novel Anti-Cancer Chemotherapeutics Key Components of ADCs Future Generation of ADCs De Novo Protein Sequencing Applications in ADC Development Introduction An antibody-drug conjugate (ADC) is a monoclonal antibody (mAb) with a covalently attached [...]

August 2022

Surface Plasmon Resonance Spectroscopy

2023-01-26T16:08:58-05:00August 16th, 2022|Articles|

Written by: Vanessa Yoon Calvelo, PhD Updated: January 19, 2023 (Published: August 11, 2022) Contents What is Surface Plasmon Resonance Spectroscopy? What is SPR Used For? How Does SPR Work? SPR Experimental Workflow SPR Sensorgram SPR Advantages SPR Applications SPR Antibody-Antigen Interaction Analysis at Rapid Novor What is [...]

August 2021

What are Monoclonal Antibodies?

2022-08-17T16:55:40-04:00August 25th, 2021|Articles|

Monoclonal antibodies (mAbs) are homogenous antibodies that bind to a single epitope on an antigen. Kohler and Milstein generated the first mAbs when they developed hybridoma technology in the 1970s. Because of the specificity, homogeneity and unlimited availability, mAbs are valuable reagents used in a variety of important applications including treatment and diagnosis of diseases